Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2025 03:01 ET | Source: CancerVAX, Inc

CancerVax Announces Successful Tests of its Smart mRNA Technology

Lehi, UT, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – February 25, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s...
December 20, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Passes First Test with Flying Colors

Lehi, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- CancerVax Passes First Test with Flying Colors Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off...
December 11, 2024 12:48 ET | Source: CancerVAX, Inc

CancerVax Targets Hard to Treat Pancreatic Cancer

Lehi, UT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- CancerVax Targets Hard to Treat Pancreatic Cancer With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC), the Company’s...
November 19, 2024 03:15 ET | Source: CancerVAX, Inc

CancerVax Lands Top Cancer Expert

Lehi, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Dr. George Katibah to serve as the Company’s Chief Scientific Officer Lehi, UT, November 19, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of...
August 29, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment

Santa Barbara, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 29, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
August 27, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform

Santa Barbara, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 27, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
August 01, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Adds Key Members to Its Research Team

Santa Barbara, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 1, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
May 21, 2024 03:00 ET | Source: CancerVAX, Inc

CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone

Santa Barbara, May 21, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, May 21, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system...
April 16, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer

Santa Barbara, April 16, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, April 16, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
April 03, 2024 03:01 ET | Source: CancerVAX, Inc

CancerVax Launches $5 Million Funding Round

Lehi, Utah, April 03, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, today announced...